tenex Revenue and Competitors
Estimated Revenue & Valuation
- tenex's estimated annual revenue is currently $217.5k per year.
- tenex's estimated revenue per employee is $72,500
Employee Data
- tenex has 3 Employees.
tenex's People
Name | Title | Email/Phone |
---|
tenex Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.8M | 50 | N/A | N/A | N/A |
#2 | $184.9M | 911 | N/A | N/A | N/A |
#3 | $1.9M | 23 | N/A | N/A | N/A |
#4 | $61M | 168 | N/A | N/A | N/A |
#5 | $0.5M | 7 | N/A | N/A | N/A |
#6 | $1.5M | 17 | N/A | N/A | N/A |
#7 | $14.9M | 103 | 10% | N/A | N/A |
#8 | $0.1M | 3 | N/A | N/A | N/A |
#9 | $1.5M | 17 | N/A | N/A | N/A |
#10 | $15.5M | 103 | N/A | N/A | N/A |
#11 | $0.4M | 6 | N/A | N/A | N/A |
#12 | $0.2M | 3 | N/A | N/A | N/A |
#13 | $7.2M | 55 | N/A | N/A | N/A |
#14 | $0.4M | 10 | N/A | N/A | N/A |
#15 | $0.5M | 10 | N/A | N/A | N/A |
#16 | $1.9M | 26 | -49% | $550K | N/A |
#17 | $8.4M | 42 | N/A | N/A | N/A |
#18 | $0.5M | 7 | N/A | N/A | N/A |
What Is tenex?
N/A
Total Funding
3
Number of Employees
$217.5k
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
tenex News
2022-04-17 - Analysis | Does Russia sell nearly $1 billion in uranium to the ...
Presumably, the TENEX sales figures combined enriched and natural uranium sales something that supposedly could not be gleaned from government...
2022-03-30 - Nonstimulant ADHD Meds: Types and Side Effects
Guanfacine (Tenex, Intuniv): alpha 2A-adrenergic receptor agonist/ blood pressure medication; Amantadine (Symmetrel): Parkinson's medication;...
2022-03-30 - FDA Clears New Soft Tissue Debridement Tool
Tenex TX1 is used for percutaneous tenotomy in orthopedics, sports medicine, pain management, and podiatry. The Ocelot system's form factor and...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.2M | 3 | N/A | N/A |
#2 | $0M | 3 | -50% | $50M |
#3 | $0.4M | 3 | N/A | N/A |
#4 | $0.3M | 3 | -91% | N/A |
#5 | N/A | 3 | 200% | N/A |